Ribovate Therapeutics

Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform.

Startup Details

Co-Founded by: Drew Weissman and Hamideh Parhiz

Participates in PCI Ventures UPstart

PCI and JPOD included in the Technical.ly Philly list of resources to boost Philly health startups

Introducing the 2021 Pennovation Accelerator Eco-Impact Cohort

PACT Recognizes Technology, Healthcare and Life Sciences Innovation and Leaders in the Philadelphia Region at the 2021 Enterprise Awards

Linnaeus Therapeutics announces expanded clinical collaboration with Merck



Skip to content